Clinical trial
POWER (Pulse Width Optimized Waveform Evaluation Trial)
NCT00311181 · Abbott Medical Devices, Industry · Completed
Key facts
| NCT number | NCT00311181 |
|---|---|
| Title | POWER (Pulse Width Optimized Waveform Evaluation Trial) |
| Official title | Phase 4 Study That Compares the DFT (Defibrillation Threshold) Efficacy of 3 Different Membrane Time Constant Based Biphasic Defibrillation Waveforms |
| Lead sponsor | Abbott Medical Devices, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Sudden Cardiac Death |
| Intervention type | Device |
| Interventions | Implantable Cardioverter Defibrillator (ICD), Cardiac Resynchronization Therapy (CRT-D) |
| Enrollment | 217 |
| Start date | Aug 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Apr 5, 2006 |
| Last update posted | Feb 20, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- 10–99 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: